Menu About us Governance Shareholders Shareholders Reporting to shareholders Financial results are announced on a quarterly basis in April, July, October and February. GSK reports formally to shareholders twice a year, when our half-year and full-year results are announced. The CEO and CFO give presentations on the half-year and full-year results in face-to-face meetings with institutional investors, analysts and the media, which are also accessible via web-cast and teleconference. You can view these presentations on GSK.com. To ensure that the Non-Executive Directors are aware of and understand the views of major shareholders, our Board has in place a briefing process, which is managed by the Chairman. It focuses on sector-specific issues as well as general shareholder preferences. Each year the Non-Executive Directors also receive an external review of shareholder opinion. Our Investor Relations department, with offices in London and Philadelphia, acts as a focal point for contacts with investors throughout the world. The CEO, CFO and Chairman maintain a dialogue with institutional shareholders on performance, plans and objectives through a programme of regular meetings. They also speak regularly at external conferences and presentations. The Company Secretary acts as a focal point for communications on corporate governance matters. We also have a small central Corporate Responsibility (CR) team which co-ordinates strategy, policy development and reporting specifically with respect to CR and communicates with socially responsible investors and other stakeholders. The Chairman meets regularly with institutional shareholders to hear their views and discuss issues of mutual importance and communicates their views to the Board. The Senior Independent Director and all the Non-Executive Directors are available to meet shareholders. The Remuneration Committee Chairman, the Chairman, the Head of Human Resources and the Company Secretary hold annual meetings with major shareholders to discuss executive remuneration and governance matters. Our Annual General Meeting (AGM) takes place in London, and notification is sent to shareholders at least one month in advance. At the Meeting a business presentation is made to shareholders and all directors able to attend are available, formally during the Meeting, and informally afterwards, for questions. Committee Chairmen ordinarily attend the AGM to respond to shareholders’ questions. The results of any voting at the meeting are released to the London Stock Exchange and published on this website. More on governance RSS Other GSK websites Market website selector GSKPro for healthcare professionals GSK Study Register Quick links COVID-19 response Behind the science About us Products Careers Investors Media Research and development Responsibility Accessibility/legal Accessibility Terms of use Cookie policy Privacy notice Modern Slavery Act statement 2020 PDF - 191.4KB Sitemap Contact us Contact us Partnerships Report a possible side effect Business to business Supplier website Business to business This is our global website, intended for visitors seeking information on GSK’s worldwide business. Our market sites can be reached by visiting our market selector. © 2001-2021 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. We use cookies GSK values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Others are optional: performance cookies show us how you use our website and features; functional cookies remember your preferences; and advertising cookies help us share relevant content.Cookie Policy Show detail ❮ OPT OUT ACCEPT ALL